<DOC>
	<DOC>NCT01756937</DOC>
	<brief_summary>Efficacy and safety of Imotun capsule in osteoarthritis of the knee</brief_summary>
	<brief_title>Efficacy and Safety of Imotun Capsule in Osteoarthritis of the Knee</brief_title>
	<detailed_description>A six-month, multi center, randomizied, double blind, parallel-group,placebo controlled study to evaluate efficacy and safety of Imotun capsule in osteoarthritis of the knee</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis, Knee</mesh_term>
	<criteria>Agreement with written informed consent and 40 years of age and older Patients with more than 63months history of OA of knee according to ACR criteria Radiographic evidence of Kellgren &amp; Lawrence grade II to III OA of the knee The 100mm Pain VAS is over 40mm The Lequensne's index is over 5 Treatment with SYSADOA within 3 months History of joint surgery within 5 years or Arthroscopic surgery within 1year Intraarticular injections within 3 months Treatment with NASIDs within 7 days Any history of adverse reaction to the study drugs clinically significant hepatic, renal, cardiovascular diseases Patients with gastrointestinal ulcers or bleeding disorders Pregnant women, nursing mothers or Fertile women who not practice contraception with appropriate methods History of drug abuse or alcoholism Patients on any other clinical trial or experimental treatment in the past 4 weeks An impossible one who participates in clinical trial by investigator's decision</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>osteoarthritis of the knee</keyword>
</DOC>